Clinical Trial Update: Rituximab to Treat Severe Hemophilia A [Phase 2]

View source ↗

Summary

Phase 2 trial results for using rituximab to treat severe Hemophilia A have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Carelon Research | Conditions: Hemophilia A | Phase 2 | Status: COMPLETED | Results posted: 2013-06-11